Gamma irradiation of collagen/mineral mixtures
    5.
    发明授权
    Gamma irradiation of collagen/mineral mixtures 失效
    胶原/矿物混合物的γ照射

    公开(公告)号:US5123925A

    公开(公告)日:1992-06-23

    申请号:US647758

    申请日:1991-01-29

    IPC分类号: A61L27/00 A61L2/00 A61L27/46

    摘要: The present invention is a method for treating bony defects. The method involves contacting the bony defect with a formable composition and allowing the formable composition to solidify. The formable composition is comprised of 2-40% of reconstituted fibrillar atelopeptide collagen and 60-98% calcium phosphate mineral by weight exclusive of moisture. After the formable composition is placed in intimate contact with the bony defect, it is allowed to solidify until it acquires an additional characteristic selected from the group consisting of a compressive modulus of at 10 N/cm.sup.2 or a tensile strength of at least 1 N/cm.sup.2. The method can be used to repair a variety of bony defects such as bone non-union, fresh fractures, periodontal bony pockets, tooth extraction sockets and jaw cysts. Further, the composition can be used to augment an alveolar ridge.

    摘要翻译: 本发明是一种治疗骨缺损的方法。 该方法包括使骨缺损与可成形组合物接触并允许可成型组合物固化。 可成型组合物由2-40%的重构纤维状三肽胶原蛋白和60-98%的磷酸钙矿物质组成,不包括水分。 将可成形组合物与骨缺损紧密接触后,使其固化,直到获得额外的特征,其选自压缩模量为10N / cm 2或拉伸强度为至少1N / cm2。 该方法可用于修复各种骨缺损,如骨不愈合,新鲜骨折,牙周骨袋,拔牙套和颌囊肿。 此外,该组合物可用于增加牙槽嵴。

    Injectable cross-linked collagen implant material
    9.
    发明授权
    Injectable cross-linked collagen implant material 失效
    注射交联胶原植入材料

    公开(公告)号:US4582640A

    公开(公告)日:1986-04-15

    申请号:US663478

    申请日:1984-10-22

    摘要: Cross-linked atelopeptide collagen that is substantially free of residual cross-linking agent is prepared by: reconstituting atelopeptide collagen from solution by neutralizing the solution at a reduced temperature and a hypotonic ionic strength; cross-linking the reconstituted fibers in an aqueous medium at a concentration of 0.1 to 10 mg/ml with glutaraldehyde under conditions that produce cross-linked collagen that when in suspension in physiological saline at a concentration of 35 mg/ml exhibits a shear viscosity whose log varies linearly with the log of the shear rate and is approximated by the formulalog .eta..ltoreq.-0.96 log .gamma.+2.3where .gamma. is the shear rate in sec.sup.-1, log .gamma. is in the range of -6 to +2 and .eta. is the viscosity of the suspension in Pascal-sec; optionally quenching the cross-linking reaction with an amino acid; and separating the cross-linked atelopeptide collagen from the reaction mixture. This collagen is dispersed in an isotonic aqueous medium for use in soft tissue dermal augmentation and is injectable and forms implants that have excellent persistence.

    摘要翻译: 通过以下方法制备基本上不含残留交联剂的交联的atelopeptide胶原蛋白:通过在降低的温度和低渗离子强度下中和溶液来重构来自溶液的阿曲肽胶原; 在产生交联胶原的条件下,用浓度为0.1至10mg / ml的水性介质在水性介质中交联重构纤维,当在浓度为35mg / ml的生理盐水中悬浮时,表现出剪切粘度, 对数随着剪切速率的对数线性变化,并且通过公式log eta = 0.96logγ+ 2.3近似,其中γ是sec-1中的剪切速率,logγ在-6至+2的范围内 eta是悬浮液的粘度(Pascal-sec); 任选地用氨基酸淬灭交联反应; 并从反应混合物中分离交联的阿肽肽胶原。 该胶原分散在等渗水性介质中,用于软组织皮肤增生,并且是可注射的并且形成具有优异持久性的植入物。